BCL2 and breast carcinoma: Additionally, another in vitro study on different types of solid tumors, i.e., hepatocellular carcinoma, breast cancer, gastric cancer, and non-small lung cancer cells, has reported the decreased levels of Bcl-2 expression in response to statins, supporting the potential of cell type-specific effects of statin [52].